Norges Bank
URGN icon

Norges Bank’s UroGen Pharma URGN Stock Holding History

Norges Bank’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,000
Closed -$868K – 2165
2020
Q3 		$868K Hold
45,000
– – ﹤0.01% 2045
2020
Q2 		$1.18M Buy
+45,000
New +$1.1M ﹤0.01% 1999
2019
Q2 		– Sell
-30,000
Closed -$1.11M – 2132
2019
Q1 		$1.11M Buy
+30,000
New +$1.26M ﹤0.01% 2047
2018
Q1 		– Sell
-1,334
Closed -$50K – 2165
2017
Q4 		$50K Hold
1,334
– – ﹤0.01% 2113
2017
Q3 		$42K Sell
1,334
-28,566
-96% -$631K ﹤0.01% 2119
2017
Q2 		$540K Buy
+29,900
New +$519K ﹤0.01% 2081

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return

Norges Bank's URGN Position: Q4 2020 in Review

Norges Bank sold out of UroGen Pharma (URGN) in Q4 2020, closing a stake of 45,000 shares — an estimated $868K sold.

Norges Bank first reported a position in URGN in Q2 2017 and held it in 6 quarters. The position peaked at $1.18M in Q2 2020. 81 funds tracked by Wall St. Rank hold URGN as of Q4 2020.

  • Norges Bank reported no remaining UroGen Pharma position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 45,000 UroGen Pharma shares in Q4 2020, an estimated $868K.
  • Norges Bank first reported a position in UroGen Pharma in Q2 2017 and held it in 6 quarters.
  • Norges Bank's UroGen Pharma position peaked at $1.18M in Q2 2020.
  • 81 funds tracked by Wall St. Rank held UroGen Pharma as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.